TD Asset Management Inc Buys 16,676 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• TD Asset Management Inc increased its stake in The Cooper Companies, Inc. by 2.5%, acquiring an additional 16,676 shares, bringing their total ownership to approximately 686,198 shares worth about $57.9 million.
• The Cooper Companies reported $1 billion in revenue for the last quarter, exceeding analysts' expectations, with a two-cents per share earnings beat at $0.96.
• The stock has recently been subjected to various analyst rating revisions, with Wells Fargo lowering its price target from $118 to $93 while several analysts maintain a positive outlook, resulting in an average target price of $96.73.

TD Asset Management Inc raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.5% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 686,198 shares of the medical device company's stock after acquiring an additional 16,676 shares during the quarter. TD Asset Management Inc owned approximately 0.34% of Cooper Companies worth $57,881,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Covestor Ltd boosted its stake in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the last quarter. Shell Asset Management Co. lifted its stake in shares of Cooper Companies by 15.5% in the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after buying an additional 127 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Cooper Companies by 16.7% in the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after purchasing an additional 129 shares during the last quarter. Axxcess Wealth Management LLC raised its holdings in shares of Cooper Companies by 1.9% in the first quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock valued at $623,000 after purchasing an additional 140 shares during the last quarter. Finally, Mitchell & Pahl Private Wealth LLC raised its holdings in shares of Cooper Companies by 1.8% in the first quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock valued at $732,000 after purchasing an additional 157 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on COO shares. Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. Piper Sandler restated an "overweight" rating and issued a $105.00 price objective (down from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 22nd. Mizuho dropped their target price on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Finally, BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research note on Tuesday, July 22nd. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus price target of $96.73.

Cooper Companies Trading Down 0.8%

Shares of NASDAQ COO traded down $0.56 during mid-day trading on Thursday, hitting $71.73. The stock had a trading volume of 572,512 shares, compared to its average volume of 2,202,593. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The business has a 50 day moving average price of $72.66 and a two-hundred day moving average price of $81.02. The firm has a market cap of $14.34 billion, a P/E ratio of 34.81, a price-to-earnings-growth ratio of 1.80 and a beta of 0.99. The Cooper Companies, Inc. has a 1 year low of $65.00 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. During the same period in the previous year, the firm earned $0.85 EPS. The company's quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.